APA (7th ed.) Citation

P, M., MP, Y., AD, A., A, P., & SE, P. (2025). No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: A prospective clinical trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 36(7), 1231. https://doi.org/10.1007/s00198-025-07538-6

Chicago Style (17th ed.) Citation

P, Makras, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, and Papapoulos SE. "No Overshoot of Bone Turnover After Withdrawal of Denosumab Treatment of Adults with Langerhans Cell Histiocytosis: A Prospective Clinical Trial." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 36, no. 7 (2025): 1231. https://doi.org/10.1007/s00198-025-07538-6.

MLA (9th ed.) Citation

P, Makras, et al. "No Overshoot of Bone Turnover After Withdrawal of Denosumab Treatment of Adults with Langerhans Cell Histiocytosis: A Prospective Clinical Trial." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 36, no. 7, 2025, p. 1231, https://doi.org/10.1007/s00198-025-07538-6.